Changes in Glycemic Outcomes Following FreeStyle Libre Initiation Among Individuals with Type 1 Diabetes, Insulin-Intensive Type 2 Diabetes, and Basal Insulin-Treated Type 2 Diabetes: A Retrospective Pre–Post Study in Saudi Arabia

Background/Objectives: Data describing glycemic changes after FreeStyle Libre (FSL) initiation in insulin-treated patients in Saudi Arabia are limited. We compared period-average HbA1c and hospital-recorded acute diabetes events (ADEs) during the 12 months before and after FSL initiation. Methods: This single-center retrospective uncontrolled pre–post cohort included 202 individuals first prescribed FSL between February and July 2023 who had at least three post-initiation sensor dispensing/refill records and no documented discontinuation. The refill criterion selects participants based on follow-up behavior. HbA1c was averaged within each 12-month period. Results: Among 202 participants (70 T1DM, 67 T2DM-MDI, 65 T2DM-Basal), mean HbA1c was 9.1 ± 1.9% before and 8.7 ± 1.8% after initiation (mean within-person change −0.44 percentage points, 95% CI −0.67 to −0.21; paired t-test p < 0.001). Within-group changes were −0.19 (p = 0.318), −0.58 (p = 0.009), and −0.55 (p = 0.008) percentage points in T1DM, T2DM-MDI, and T2DM-Basal, respectively. Between-group differences in change were not significant (ANOVA p = 0.316; Kruskal–Wallis p = 0.137); the common-slope ANCOVA group effect was nonsignificant (F[2, 198] = 1.58, p = 0.208), but the group × baseline HbA1c interaction was significant (F[2, 196] = 4.27, p = 0.015). Exploratory conditional pairwise contrasts at baseline HbA1c levels of 8%, 9% and 10% were not significant after multiplicity adjustment. Exploratory baseline-HbA1c strata were not multiplicity-adjusted and are vulnerable to regression to the mean. ADE counts were sparse. Conclusions: Lower mean HbA1c was observed after FSL initiation among selected patients, particularly in the two T2DM groups within-group; an independent FSL effect cannot be inferred without a comparator or treatment-change information.

Authors

Institutions

Publication Details

Journal
Healthcare
Published
2026-11-16
DOI
https://doi.org/10.3390/healthcare14223931
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Changes in Glycemic Outcomes Following FreeStyle Libre Initiation Among Individuals with Type 1 Diabetes, Insulin-Intensive Type 2 Diabetes, and Basal Insulin-Treated Type 2 Diabetes: A Retrospective Pre–Post Study in Saudi Arabia

Raed Aldahash, Ahmed R Alibrahim, Saeed Mastour Alshahrani, Meshari Al Samih et al.
3 links
Healthcare
Diabetes Management and Research
article

Changes in Glycemic Outcomes Following FreeStyle Libre Initiation Among Individuals with Type 1 Diabetes, Insulin-Intensive Type 2 Diabetes, and Basal Insulin-Treated Type 2 Diabetes: A Retrospective Pre–Post Study in Saudi Arabia

Raed Aldahash, Ahmed R Alibrahim, Saeed Mastour Alshahrani, Meshari Al Samih, Mohammed Alkhalaf, Nawaf Alagrafy, Yazeed Alqahtani
article en

Abstract

Background/Objectives: Data describing glycemic changes after FreeStyle Libre (FSL) initiation in insulin-treated patients in Saudi Arabia are limited. We compared period-average HbA1c and hospital-recorded acute diabetes events (ADEs) during the 12 months before and after FSL initiation. Methods: This single-center retrospective uncontrolled pre–post cohort included 202 individuals first prescribed FSL between February and July 2023 who had at least three post-initiation sensor dispensing/refill records and no documented discontinuation. The refill criterion selects participants based on follow-up behavior. HbA1c was averaged within each 12-month period. Results: Among 202 participants (70 T1DM, 67 T2DM-MDI, 65 T2DM-Basal), mean HbA1c was 9.1 ± 1.9% before and 8.7 ± 1.8% after initiation (mean within-person change −0.44 percentage points, 95% CI −0.67 to −0.21; paired t-test p < 0.001). Within-group changes were −0.19 (p = 0.318), −0.58 (p = 0.009), and −0.55 (p = 0.008) percentage points in T1DM, T2DM-MDI, and T2DM-Basal, respectively. Between-group differences in change were not significant (ANOVA p = 0.316; Kruskal–Wallis p = 0.137); the common-slope ANCOVA group effect was nonsignificant (F[2, 198] = 1.58, p = 0.208), but the group × baseline HbA1c interaction was significant (F[2, 196] = 4.27, p = 0.015). Exploratory conditional pairwise contrasts at baseline HbA1c levels of 8%, 9% and 10% were not significant after multiplicity adjustment. Exploratory baseline-HbA1c strata were not multiplicity-adjusted and are vulnerable to regression to the mean. ADE counts were sparse. Conclusions: Lower mean HbA1c was observed after FSL initiation among selected patients, particularly in the two T2DM groups within-group; an independent FSL effect cannot be inferred without a comparator or treatment-change information.

HealthcareVol. 14(22)
King Saud bin Abdulaziz University for Health Sciences (SA), King Abdulaziz Medical City (SA), National Guard Health Affairs (SA), King Khalid University (SA)
Abbott Diabetes Care
Good health and well-being
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon